Incyte to Report Fourth Quarter and Year-End Financial Results
January 23 2020 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
fourth quarter and year-end 2019 financial results conference call
and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.
The schedule for the press release and conference call/webcast
is as follows:
- Q4 & YE 2019 Press Release:
February 13, 2020 at 7:00 a.m.
ET
- Q4 & YE 2019 Conference Call:
February 13, 2020 at 8:00 a.m.
ET
877-407-3042
- International Dial-In Number:
201-389-0864
13698234
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13698234.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for 30
days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical
company focused on finding solutions for serious unmet medical
needs through the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte,
please visit Incyte.com and follow @Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200123005007/en/
Incyte Contacts Media
Catalina Loveman +1 302 498 6171 cloveman@incyte.com
Investors Michael Booth, DPhil +1 302 498 5914
mbooth@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024